Testing effectiveness (Phase 2)UnknownNCT02036086
What this trial is testing
Study of Neo-adjuvant Use of Vemurafenib Plus Cobimetinib for BRAF Mutant Melanoma With Palpable Lymph Node Metastases
Who this might be right for
Melanoma
Sunnybrook Health Sciences Centre 24